Evogene (EVGN) Quick Ratio: History & Chart

Evogene Ltd.(EVGN)

Biotechnology · Rehovot, HM

$0.42+0.02 (+4.93%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Evogene Ltd.

Evogene Ltd., along with its subsidiaries, operates as a computational biology firm. Its core activity involves the discovery and advancement of products across diverse life-science sectors, such as human health and agriculture, primarily leveraging its proprietary Computational Predictive Biology (CPB) platform. This platform, built on deep biological insights, big data analytics, and artificial intelligence, is engineered to digitally identify and strategically guide the creation of life-science solutions derived from microbes, small molecules, and genetic components. The company's operations are structured into three primary divisions: Agriculture, Human Health, and Industrial Applications. Within the Agriculture division, Evogene works on seed traits, agricultural chemicals, and biological products aimed at improving plant yields, with efforts spanning critical crops like corn, soybean, wheat, rice, and cotton. The Industrial Applications segment focuses on enhancing castor bean seeds for use as a raw material in various industrial applications. Meanwhile, the Human Health segment is dedicated to uncovering and developing human microbiome-based treatments for conditions including immuno-oncology, gastrointestinal disorders, and antimicrobial-resistant infections. Beyond these core areas, Evogene also delivers medical cannabis products. The company maintains a global presence, conducting operations in the United States, Israel, Brazil, and other international markets. It has forged key partnerships and licensing agreements with leading agricultural enterprises, such as BASF SE, Corteva, and Bayer. Additionally, its subsidiary, Canonic Ltd., collaborates with Cannbit Ltd. on the development of innovative medical cannabis offerings. Established in 1999, Evogene Ltd. is based in Rehovot, Israel.

Rehovot, HM

52 employees

www.evogene.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Ofer Haviv

View full financials

EVGN Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

3.54

QUICK RATIO (ACID-TEST) AVG TTM

3.42

QUICK RATIO (ACID-TEST) AVG 3Y

3.33

QUICK RATIO (ACID-TEST) AVG 5Y

5.14

QUICK RATIO (ACID-TEST) AVG 10Y

8.82

QUICK RATIO (ACID-TEST) AVG 15Y

10.31

QUICK RATIO (ACID-TEST) AVG 20Y

N/A

CURRENT VS TTM AVG

+3.24%

CURRENT VS 3Y AVG

+6.03%

CURRENT VS 5Y AVG

-31.28%

CURRENT VS 10Y AVG

-59.91%

CURRENT VS 15Y AVG

-65.71%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

3.35

median of 871 covered companies

CURRENT VS SECTOR MEDIAN

+5.53%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
Evogene Ltd. (EVGN)	$3.65M	3.54	3.42	3.33	5.14
Ernexa Therapeutics Inc. (ERNA)vs ›	$3.65M	2.01	0.91	1.26	1.78
WORK Medical Technology Group Ltd. Class A (WOK)vs ›	$3.63M	0.82	1.40	1.07	0.94
Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs ›	$3.53M	3.73	3.25	4.33	4.33
Moolec Science S.A. (MLEC)vs ›	$3.50M	0.08	0.52	0.43	0.47
Eocene Ltd. (EOCN)vs ›	$3.50M	N/A	N/A	N/A	N/A
Mustang Bio, Inc. (MBIO)vs ›	$3.49M	1.97	1.45	2.21	4.94
60 Degrees Pharmaceuticals, Inc. (SXTP)vs ›	$3.90M	1.78	2.64	1.92	1.57
Aptevo Therapeutics Inc. (APVO)vs ›	$3.93M	2.08	2.77	2.83	2.68
Nexalin Technology, Inc. (NXL)vs ›	$3.30M	1.10	5.81	5.76	3.90

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

Evogene Ltd. (EVGN)

$3.65M

3.54

3.42

3.33

5.14

Ernexa Therapeutics Inc. (ERNA)vs ›

$3.65M

2.01

0.91

1.26

1.78

WORK Medical Technology Group Ltd. Class A (WOK)vs ›

$3.63M

0.82

1.40

1.07

0.94

Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs ›

$3.53M

3.73

3.25

4.33

Moolec Science S.A. (MLEC)vs ›

$3.50M

0.08

0.52

0.43

0.47

Eocene Ltd. (EOCN)vs ›

$3.50M

N/A

Mustang Bio, Inc. (MBIO)vs ›

$3.49M

1.97

1.45

2.21

4.94

60 Degrees Pharmaceuticals, Inc. (SXTP)vs ›

$3.90M

1.78

2.64

1.92

1.57

Aptevo Therapeutics Inc. (APVO)vs ›

$3.93M

2.08

2.77

2.83

2.68

Nexalin Technology, Inc. (NXL)vs ›

$3.30M

1.10

5.81

5.76

3.90

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Evogene Ltd. (EVGN)?

The quick ratio (acid-test) for EVGN stock is 3.54.

Is Evogene Ltd.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 3.54 is 31% below its 5-year average of 5.14, near the low end of its 5-year range (0.92–12.74).

What is the TTM average quick ratio (acid-test) for Evogene Ltd. (EVGN)?

The TTM average quick ratio (acid-test) for EVGN stock is 3.42.

What is the 3Y average quick ratio (acid-test) for Evogene Ltd. (EVGN)?

The 3Y average quick ratio (acid-test) for EVGN stock is 3.33.

What is the 5Y average quick ratio (acid-test) for Evogene Ltd. (EVGN)?

The 5Y average quick ratio (acid-test) for EVGN stock is 5.14.

What is the 10Y average quick ratio (acid-test) for Evogene Ltd. (EVGN)?

The 10Y average quick ratio (acid-test) for EVGN stock is 8.82.

What is the 15Y average quick ratio (acid-test) for Evogene Ltd. (EVGN)?

The 15Y average quick ratio (acid-test) for EVGN stock is 10.31.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	3.54
2026-03-31	2.76
2025-12-31	4.48
2025-09-30	4.59
2025-06-30	1.76
2025-03-31	0.92
2024-12-31	1.06
2024-09-30	1.03
2024-06-30	1.53
2024-03-31	4.94
2023-12-31	4.95
2023-09-30	6.24
2023-06-30	5.55
2023-03-31	5.75
2022-12-31	6.61
2022-09-30	7.27
2022-06-30	6.78
2022-03-31	7.55
2021-12-31	8.25
2021-09-30	9.72
2021-06-30	12.74
2021-03-31	13.65
2020-12-31	5.36
2020-09-30	9.78
2020-06-30	8.26
2020-03-31	9.55
2019-12-31	8.53
2019-09-30	11.38
2019-06-30	10.14
2019-03-31	9.88
2018-12-31	10.22
2018-09-30	11.86
2018-06-30	12.96
2018-03-31	14.54
2017-12-31	15.61
2017-09-30	16.70
2017-06-30	17.66
2017-03-31	15.15
2016-12-31	17.13
2016-09-30	17.04
2016-06-30	18.10
2016-03-31	22.20
2015-12-31	18.51
2015-09-30	22.85
2015-06-30	20.36
2015-03-31	19.79
2014-12-31	14.95
2014-09-30	17.83
2014-06-30	17.55
2014-03-31	17.82
2013-12-31	15.11
2013-09-30	6.11
2013-06-30	5.97
2013-03-31	6.76
2012-12-31	6.03
2012-09-30	7.19
2012-06-30	7.15

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

3.54

2026-03-31

2.76

2025-12-31

4.48

2025-09-30

4.59

2025-06-30

1.76

2025-03-31

0.92

2024-12-31

1.06

2024-09-30

1.03

2024-06-30

1.53

2024-03-31

4.94

2023-12-31

4.95

2023-09-30

6.24

2023-06-30

5.55

2023-03-31

5.75

2022-12-31

6.61

2022-09-30

7.27

2022-06-30

6.78

2022-03-31

7.55

2021-12-31

8.25

2021-09-30

9.72

2021-06-30

12.74

2021-03-31

13.65

2020-12-31

5.36

2020-09-30

9.78

2020-06-30

8.26

2020-03-31

9.55

2019-12-31

8.53

2019-09-30

11.38

2019-06-30

10.14

2019-03-31

9.88

2018-12-31

10.22

2018-09-30

11.86

2018-06-30

12.96

2018-03-31

14.54

2017-12-31

15.61

2017-09-30

16.70

2017-06-30

17.66

2017-03-31

15.15

2016-12-31

17.13

2016-09-30

17.04

2016-06-30

18.10

2016-03-31

22.20

2015-12-31

18.51

2015-09-30

22.85

2015-06-30

20.36

2015-03-31

19.79

2014-12-31

14.95

2014-09-30

17.83

2014-06-30

17.55

2014-03-31

17.82

2013-12-31

15.11

2013-09-30

6.11

2013-06-30

5.97

2013-03-31

6.76

2012-12-31

6.03

2012-09-30

7.19

2012-06-30

7.15

Quick Ratio (Acid-Test): 3.54

EVGN Quick Ratio

EVGN Average Quick Ratio (Acid-Test) Chart

EVGN Current vs Average Quick Ratio (Acid-Test) Chart

EVGN Quick Ratio (Acid-Test) Metrics

EVGN Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

EVGN Quick Ratio (Acid-Test) History

Related Metrics